
Insider and congress filings
Cigna Corporation (CI)
NYSE · Healthcare · 338 insider transactions · 137 congress trades · last filed 2 months agoS&P 500
About Cigna Corporation
from the company's filings and listing, as of Oct 23, 2026- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- Chief executive
- Brian C. Evanko
- Employees
- 66,685
- Listed since
- Mar 31, 1982
- Market value
- $83.5B
- Price to earnings (12 mo)
- 13.0
- Net income per share, as reported (12 mo)
- $24.31
- Dividend yield
- 1.96%
Earnings
6 reported quarters · next on Nov 5, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 30, 2026 | $7.78 | $7.60 | $71.7B | $70.1B | EPS beatRevenue beat |
| Q1 FY2026reported Apr 30, 2026 | $7.79 | $7.60 | $68.5B | $66.3B | EPS beatRevenue beat |
| Q4 FY2025reported Feb 5, 2026 | $8.08 | $7.88 | $72.5B | $70.3B | EPS beatRevenue beat |
| Q3 FY2025reported Oct 30, 2025 | $7.83 | $7.64 | $69.7B | $67.6B | EPS beatRevenue beat |
| Q2 FY2025reported Jul 31, 2025 | $7.20 | $7.16 | $67.2B | $62.9B | EPS in lineRevenue beat |
| Q1 FY2025reported May 2, 2025 | $6.74 | $6.35 | $65.5B | $60.2B | EPS beatRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for fiscal 2025 · proxy filed Mar 13, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| David M. CordaniChair and Chief Executive Officer | $1.6M | $13.9M | $7.3M | $22.9M |
| Brian C. EvankoPresident and Chief Operating Officer | $1.1M | $5.1M | $3.9M | $10.0M |
| Nicole S. JonesExecutive Vice President, Chief Administrative Officer, and General Counsel | $893K | $2.9M | $2.1M | $6.0M |
| Ann M. DennisonExecutive Vice President, Chief Financial Officer, The Cigna Group | $773K | $2.3M | $1.6M | $4.7M |
| Everett NevilleExecutive Vice President, Strategy and Business Development | $800K | $1.7M | $1.6M | $4.1M |
The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. Executives who have since left are not shown. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Shares vs prior qtr | % of shares out |
|---|---|---|---|---|
| BlackRock, Inc. | $6.5B | 23,438,250 | +3.7% | 8.88% |
| Vanguard Capital Management LLC | $4.8B | 17,276,296 | +0.9% | 6.54% |
| State Street Corp | $3.5B | 12,682,259 | +3.2% | 4.83% |
| Dodge & Cox | $3.4B | 12,173,875 | +5.3% | 4.61% |
| Massachusetts Financial Services Co | $2.9B | 10,443,691 | -9.9% | 3.96% |
| Sanders Capital, LLC | $2.8B | 10,144,617 | -1.4% | 3.84% |
| FMR LLC | $2.2B | 8,018,189 | -26.8% | 3.04% |
| Geode Capital Management, LLC | $1.7B | 6,268,347 | +1.1% | 2.37% |
| Vanguard Portfolio Management LLC | $1.7B | 6,228,614 | +1.1% | 2.36% |
| GQG Partners LLC | $1.6B | 5,908,707 | -1.6% | 2.24% |
| JPMorgan Chase & Co. | $1.4B | 5,194,363 | -10.5% | 1.97% |
| Morgan Stanley | $1.0B | 3,690,812 | +7.5% | 1.40% |
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
Tracked fund managers holding CI
4 managers| Manager | Value | Shares | Share of book |
|---|---|---|---|
| Two Sigma | $499.8M | 1,813,110 | 0.4% |
| Glenview CapitalLarry Robbins | $113.6M | 412,223 | 2.1% |
| Leon CoopermanOmega Advisors | $89.6M | 325,000 | 2.5% |
| David EinhornGreenlight Capital | $24.4M | 88,400 | 0.6% |
4 of the 97 fund managers we track list CI shares among the largest positions in their latest 13F, filed for Q2 2026. A manager can hold it further down the book too, so this is a floor, not a count. Share of book is the position against the manager's whole disclosed 13F value.
Open-market insider trades
5 filings shown · newest filing first| Insider | Action | Shares | Price | Value | Trade date | Delay (business days) |
|---|---|---|---|---|---|---|
| Everett Neville | Sold · scheduled | 617 | $284.05 | $175K | Sep 3, 2026filed Sep 8, 2026 | 2d |
| Nicole S. Jones | Sold · scheduled | 2,677 | $279.61 | $749K | Aug 18, 2026filed Aug 20, 2026 | 2d |
| Nicole S. Jones | Sold · scheduled | 19,436 | $276.27 | $5.4M | Aug 4, 2026filed Aug 6, 2026 | 2d |
| Jamie G. KatesChief Accounting Officer | Sold | 899 | $298.61 | $268K | Jun 12, 2026filed Jun 16, 2026 | 2d |
| David CordaniChairman & CEO | Sold · scheduled · 13 lines | 201,878 | $292.82 | $59.1M | May 12, 2026filed May 14, 2026 | 2d |
One row is one filing, newest filing first. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count. Scheduled: set up in advance under a Rule 10b5-1 trading plan. The delay counts business days from the trade to the filing, the unit of Form 4's two business day deadline: weekends and federal holidays are skipped. How the filing itself works is explained in our guide to Form 4.
Other Form 4 activity (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| Brian C. Evanko | Stock award | 9,829 | Sep 1, 2026 |
| George KurianDirector | Stock award | 109 | Aug 31, 2026 |
| Bryan Holgerson | Stock award | 0.887 | Jul 9, 2026 |
| Bryan Holgerson | Stock award | 0.946 | Jul 23, 2026 |
| Bryan Holgerson | Stock award | 0.984 | Aug 6, 2026 |
| Nicole S. Jones | Option exercise | 1,301 | Aug 5, 2026 |
| Nicole S. Jones | Option exercise | 14,045 | Aug 4, 2026 |
| Matthew Perlberg | Other Form 4 entry (see filing) | 6,343 | Mar 1, 2026 |
| Matthew Perlberg | Other Form 4 entry (see filing) | 5,658 | Mar 1, 2025 |
| Matthew Perlberg | Other Form 4 entry (see filing) | 791 | Mar 1, 2023 |
| Matthew Perlberg | Other Form 4 entry (see filing) | 3,136 | Mar 1, 2024 |
| Jason D. Sadler | Other Form 4 entry (see filing) | 5,791 | Mar 1, 2026 |
| Jason D. Sadler | Other Form 4 entry (see filing) | 6,257 | Mar 1, 2024 |
| Jason D. Sadler | Other Form 4 entry (see filing) | 5,400 | Mar 1, 2025 |
| Adam Kautzner | Other Form 4 entry (see filing) | 8,708 | Mar 1, 2026 |
| Adam Kautzner | Other Form 4 entry (see filing) | 5,955 | Mar 1, 2025 |
| Adam Kautzner | Other Form 4 entry (see filing) | 3,764 | Mar 1, 2024 |
| Adam Kautzner | Other Form 4 entry (see filing) | 1,778 | Mar 1, 2023 |
| Adam Kautzner | Other Form 4 entry (see filing) | 2,008 | Mar 1, 2022 |
| Adam Kautzner | Other Form 4 entry (see filing) | 1,579 | Feb 26, 2021 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Congress trades in CI
20 disclosures of 137 on record · median 28d of the 45 allowedSince the trade: the stock's move from the trade date to the latest close we hold (figures as of Oct 25, 2026), not the member's result. Not investment advice.
| Member | Type | Action | Amount disclosed | Stock since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +8.1%After the saleS&P 500 +2.4% · +5.7 pts vs S&P 500 | Jul 20, 2026 | Aug 7, 2026 | 18d |
| Julie JohnsonJointFiled late | Stock | Sale | $1,001 - $15,000 | +5.8%After the saleS&P 500 +14.2% · -8.4 pts vs S&P 500 | Sep 23, 2025 | Aug 5, 2026 | 316d |
| Julie JohnsonJointFiled late | Stock | Purchase | $1,001 - $15,000 | +5.8%S&P 500 +14.2% · -8.4 pts vs S&P 500 | Sep 23, 2025 | Aug 5, 2026 | 316d |
| Alan ArmstrongSelf | Stock | Purchase | $1,001 - $15,000 | +17.2%S&P 500 +19.8% · -2.7 pts vs S&P 500 | Mar 27, 2026 | Jul 21, 2026 | 116d |
| Ro Khanna | Stock | Sale | $15,001 - $50,000 | +12.6%After the saleS&P 500 +0.1% · +12.5 pts vs S&P 500 | Jun 2, 2026 | Jul 6, 2026 | 34d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +7.6%S&P 500 +2.8% · +4.8 pts vs S&P 500 | May 15, 2026 | Jun 9, 2026 | 25d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +11.4%After the saleS&P 500 +6.4% · +4.9 pts vs S&P 500 | Apr 24, 2026 | May 11, 2026 | 17d |
| Ro Khanna | Stock | Sale | $15,001 - $50,000 | +11.6%After the saleS&P 500 +10.8% · +0.8 pts vs S&P 500 | Apr 13, 2026 | May 11, 2026 | 28d |
| Jared MoskowitzDependent child | Stock | Sale | $1,001 - $15,000 | +17.4%After the saleS&P 500 +15.6% · +1.8 pts vs S&P 500 | Mar 23, 2026 | Apr 30, 2026 | 38d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | +14.9%After the saleS&P 500 +14.7% · +0.2 pts vs S&P 500 | Mar 13, 2026 | Apr 7, 2026 | 25d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +5.6%S&P 500 +11.2% · -5.6 pts vs S&P 500 | Feb 17, 2026 | Mar 9, 2026 | 20d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +9.2%S&P 500 +10.5% · -1.3 pts vs S&P 500 | Feb 24, 2026 | Mar 9, 2026 | 13d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +12.9%S&P 500 +9.5% · +3.4 pts vs S&P 500 | Jan 13, 2026 | Feb 6, 2026 | 24d |
| Ro Khanna | Stock | Purchase | $15,001 - $50,000 | +13.2%S&P 500 +9.5% · +3.7 pts vs S&P 500 | Jan 29, 2026 | Feb 6, 2026 | 8d |
| Julie JohnsonJoint | Stock | Sale | $1,001 - $15,000 | +12.0%After the saleS&P 500 +12.3% · -0.3 pts vs S&P 500 | Dec 18, 2025 | Jan 15, 2026 | 28d |
| Julia LetlowFiled late | Stock | Purchase | $1,001 - $15,000 | -3.3%S&P 500 +31.5% · -34.8 pts vs S&P 500 | Oct 23, 2024 | Jan 13, 2026 | 447d |
| Julia LetlowFiled late | Stock | Sale | $1,001 - $15,000 | -8.9%After the saleS&P 500 +44.3% · -53.2 pts vs S&P 500 | Apr 22, 2025 | Jan 13, 2026 | 266d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | +12.9%S&P 500 +11.3% · +1.6 pts vs S&P 500 | Dec 19, 2025 | Jan 12, 2026 | 24d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | +13.4%After the saleS&P 500 +11.2% · +2.2 pts vs S&P 500 | Nov 12, 2025 | Dec 15, 2025 | 33d |
| Julie JohnsonJoint | Stock | Sale | $1,001 - $15,000 | +13.3%After the saleS&P 500 +13.0% · +0.3 pts vs S&P 500 | Nov 13, 2025 | Dec 11, 2025 | 28d |
Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no since-the-trade figure is computed from them.
Every Congress trade in CI, filterable by party, chamber, type and account.
Members of Congress reporting a position
6 members · estimate, as of Oct 22, 20266 members report a position (estimated). The largest estimated position is in the $50,001 - $100,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| J. French Hill | Republican · House | $50,001 - $100,000 | 0.5% |
| Lucy McBath | Democrat · House | $50,001 - $100,000 | 0.8% |
| Mark Harris | Republican · House | $15,001 - $50,000 | 1.3% |
| Robert Bresnahan | Republican · House | $15,001 - $50,000 | 0.1% |
| Donald Norcross | Democrat · House | $1,001 - $15,000 | 7.4% |
| Robert B. Aderholt | Republican · House | $1,001 - $15,000 | 1.1% |
Estimate, as of Oct 22, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Questions
Are insiders buying or selling CI?
Across the 5 most recent open-market filings shown here, 0 were purchases and 5 were sales. 4 were scheduled in advance under a Rule 10b5-1 plan.
Which members of Congress have traded CI?
Ro Khanna, Julie Johnson, Alan Armstrong, Jared Moskowitz, Gilbert Ray Cisneros, Jr. and Julia Letlow disclosed CI transactions in the filings shown here.
Which members of Congress hold CI?
6 members of Congress report a position in CI in the estimate we hold as of Oct 22, 2026. The two largest estimated positions belong to J. French Hill and Lucy McBath; Mark Harris holds one of the next largest, in the $15,001 - $50,000 band. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Is CI in the S&P 500 or the Nasdaq 100?
Cigna Corporation is a current member of the S&P 500, per the membership list we hold as of Oct 26, 2026. Current members of either index get a page here whatever their filing history.
How quickly are CI trades disclosed?
Insider filings on this page reached the public a median of 2 business days after the transaction (weekends and federal holidays skipped), against the two business days Form 4 allows. Congressional disclosures took a median of 28 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 26, 2026.
